Dezamizumab

For research use only. Not for therapeutic Use.

  • CAT Number: I042234
  • CAS Number: 1662664-56-3
  • Purity: ≥95%
Inquiry Now

Dezamizumab (GSK 2398852) is a fully humanized recombinant monoclonal IgG1 anti-serum amyloid P component (SAP) antibody, with potential anti-amyloid activity. Dezamizumab triggers immunotherapeutic clearance of amyloid. Dezamizumab can be used in research of Amyloid light-chain (AL) amyloidosis[1].


Catalog Number I042234
CAS Number 1662664-56-3
Purity ≥95%
Reference

[1]. Parrondo RD, et, al. Antibody-based immunotherapy for treatment of immunoglobulin light-chain amyloidosis. Br J Haematol. 2020 Dec;191(5):673-681.
[Content Brief]

Request a Quote